Percolation onset and conductivity of nanocomposites assuming an incomplete dispersion of graphene nanosheets in a polymer matrix-Reference-Cited by-同舟云学术

Percolation onset and conductivity of nanocomposites assuming an incomplete dispersion of graphene nanosheets in a polymer matrix

Published:2023 Issue:47 Volume:25 Page:32460-32470
ISSN:1463-9076
Container-title:Physical Chemistry Chemical Physics
language:en
Short-container-title:Phys. Chem. Chem. Phys.

Author:

Zare Yasser¹^ORCID,Munir Muhammad Tajammal²,Rhee Kyong Yop³

Affiliation:

1. Biomaterials and Tissue Engineering Research Group, Department of Interdisciplinary Technologies, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran

2. College of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait

3. Department of Mechanical Engineering (BK21 four), College of Engineering, Kyung Hee University, Yongin, Republic of Korea

Abstract

Graphene nanosheet stacks are considered, and the percolation onset, actual filler amount and portion of networked nanosheets are specified. These terms are also applied to develop a model for the conductivity of a graphene-filled system.

Publisher

Royal Society of Chemistry (RSC)

Subject

Physical and Theoretical Chemistry,General Physics and Astronomy

Link

http://pubs.rsc.org/en/content/articlepdf/2023/CP/D3CP04375D

Reference58 articles.

1. Molecular dynamics study of the interactions between a hydrophilic polymer brush on graphene and amino acid side chain analogues in water

2. The superior effect of edge functionalization relative to basal plane functionalization of graphene in enhancing the thermal conductivity of polymer–graphene nanocomposites – a combined molecular dynamics and Green's functions study

3. N, S-doped graphene derived from graphene oxide and thiourea-formaldehyde resin for high stability lithium–sulfur batteries

4. Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product

5. Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product